Grown Rogue International (GRUSF) Current Deferred Revenue (2014 - 2023)
Grown Rogue International's (GRUSF) quarterly Current Deferred Revenue came in at -$20667.5 in Q4 2023, up 71.22% year-on-year from -$12070.6 in Q4 2022, and down 172.75% quarter-over-quarter from $28409.0 in Q2 2023.
Grown Rogue International (GRUSF) Current Deferred Revenue (2014 - 2023) Analysis & Trends
Grown Rogue International's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at -$20667.5 for Q4 2023.
- On a quarterly basis, Current Deferred Revenue rose 71.22% year-over-year to -$20667.5 in Q4 2023; TTM through Oct 2023 was -$20667.5, a 71.22% increase from a year earlier, with the FY2023 full-year figure at -$20784.6, down 174.17% from the prior year.
- Current Deferred Revenue fell to -$20667.5 in Q4 2023 per GRUSF's latest filing, from $28409.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $84600.0 in Q1 2021 and bottomed at -$71817.9 in Q4 2022.
- The 4-year median for Current Deferred Revenue is $35000.0 (2019), against an average of $21120.2.
- Biggest YoY gain for Current Deferred Revenue was 71.22% in 2023; the steepest drop was 71.22% in 2023.
- Year by year, Current Deferred Revenue stood at $35000.0 in 2019, then rose by 14.29% to $40000.0 in 2021, then sank by 279.54% to -$71817.9 in 2022, then jumped by 71.22% to -$20667.5 in 2023.
- Per Business Quant, the three latest GRUSF Current Deferred Revenue figures stand at -$20667.5 (Q4 2023), $28409.0 (Q2 2023), and $52318.0 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -20,667.53 |
| Apr 30, 2023 | 28,409.00 |
| Jan 31, 2023 | 52,318.00 |
| Oct 31, 2022 | -71,817.94 |
| Apr 30, 2021 | 40,000.00 |
| Jan 31, 2021 | 84,600.00 |
| Oct 31, 2019 | 35,000.00 |
| Feb 28, 2015 | -193,440.49 |
| Nov 30, 2014 | -147,690.01 |
| Aug 31, 2014 | 164,270.89 |